Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5971)
All Articles published online
|
Publishing Process of This Article
|
Jul 14, 2014 (publication date) through Apr 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Paik WH, Ryu JK, Jeong KS, Park JM, Song BJ, Lee SH, Kim YT, Yoon YB. Clobenpropit enhances anti-tumor effect of gemcitabine in pancreatic cancer. World J Gastroenterol 2014; 20(26): 8545-8557 [PMID: 25024609 DOI: 10.3748/wjg.v20.i26.8545] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i26/8545.htm |
| Number | Citing Articles |
| 1 |
Xiaojia Ji, Kevin P Williams, Weifan Zheng. Applying a Gene Reversal Rate Computational Methodology to Identify Drugs for a Rare Cancer: Inflammatory Breast Cancer. Cancer Informatics 2023; 22 doi: 10.1177/11769351231202588
|
| 2 |
Yan-yan Zhao, Jing Jia, Jing-jing Zhang, Yan-ping Xun, Shu-jun Xie, Jia-feng Liang, Hong-gang Guo, Jia-zhen Zhu, Sheng-lin Ma, Shi-rong Zhang. Inhibition of histamine receptor H3 suppresses the growth and metastasis of human non-small cell lung cancer cells via inhibiting PI3K/Akt/mTOR and MEK/ERK signaling pathways and blocking EMT. Acta Pharmacologica Sinica 2021; 42(8): 1288 doi: 10.1038/s41401-020-00548-6
|
| 3 |
Alana Aragón-Herrera, Marinela Couselo-Seijas, Sandra Feijóo-Bandín, Laura Anido-Varela, Sandra Moraña-Fernández, Estefanía Tarazón, Esther Roselló-Lletí, Manuel Portolés, José Luis Martínez-Sande, Javier García-Seara, Ezequiel Álvarez, José Ramón González-Juanatey, Moisés Rodríguez-Mañero, Sonia Eiras, Francisca Lago. Relaxin-2 plasma levels in atrial fibrillation are linked to inflammation and oxidative stress markers. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-26836-1
|
| 4 |
Takuji Tanaka, Takahiro Kochi, Yohei Shirakami, Takayuki Mori, Ayumi Kurata, Naoki Watanabe, Hisataka Moriwaki, Masahito Shimizu. Cimetidine and Clobenpropit Attenuate Inflammation-Associated Colorectal Carcinogenesis in Male ICR Mice. Cancers 2016; 8(2): 25 doi: 10.3390/cancers8020025
|
| 5 |
Noelia A Massari, Melisa B Nicoud, Vanina A Medina. Histamine receptors and cancer pharmacology: an update. British Journal of Pharmacology 2020; 177(3): 516 doi: 10.1111/bph.14535
|
| 6 |
Enrique Domínguez‐Álvarez, Dorota Łażewska, Zsanett Szabó, Stefanie Hagenow, David Reiner, Márió Gajdács, Gabriella Spengler, Holger Stark, Jadwiga Handzlik, Katarzyna Kieć‐Kononowicz. The Search for Histamine H4 Receptor Ligands with Anticancer Activity among Novel (Thio)urea Derivatives. ChemistrySelect 2019; 4(36): 10943 doi: 10.1002/slct.201902747
|
| 7 |
Tamara E. Galarza, Mónica A. Táquez Delgado, Nora A. Mohamad, Gabriela A. Martín, Graciela P. Cricco. Histamine H4 receptor agonists induce epithelial-mesenchymal transition events and enhance mammosphere formation via Src and TGF-β signaling in breast cancer cells. Biochemical Pharmacology 2020; 180: 114177 doi: 10.1016/j.bcp.2020.114177
|
| 8 |
Adriana María Belén Abiuso, María Luisa Varela, Luis Haro Durand, Marcos Besio Moreno, Alejandra Marcos, Roberto Ponzio, Marco Aurelio Rivarola, Alicia Belgorosky, Omar Pedro Pignataro, Esperanza Berensztein, Carolina Mondillo. Histamine H4 receptor as a novel therapeutic target for the treatment of Leydig-cell tumours in prepubertal boys. European Journal of Cancer 2018; 91: 125 doi: 10.1016/j.ejca.2017.12.003
|
| 9 |
Melisa B. Nicoud, Karina Formoso, Vanina A. Medina. Pathophysiological Role of Histamine H4 Receptor in Cancer: Therapeutic Implications. Frontiers in Pharmacology 2019; 10 doi: 10.3389/fphar.2019.00556
|
| 10 |
Phuong Linh Nguyen, Jungsook Cho. Pathophysiological Roles of Histamine Receptors in Cancer Progression: Implications and Perspectives as Potential Molecular Targets. Biomolecules 2021; 11(8): 1232 doi: 10.3390/biom11081232
|
| 11 |
Tamara E. Galarza, Nora A. Mohamad, Mónica A. Táquez Delgado, Guadalupe M. Vedoya, Ernesto J. Crescenti, Rosa M. Bergoc, Gabriela A. Martín, Graciela P. Cricco. Histamine prevents radiation-induced mesenchymal changes in breast cancer cells. Pharmacological Research 2016; 111: 731 doi: 10.1016/j.phrs.2016.07.039
|
| 12 |
Dominik Awad, Michael Prattes, Lisa Kofler, Ingrid Rössler, Mathias Loibl, Melanie Pertl, Gertrude Zisser, Heimo Wolinski, Brigitte Pertschy, Helmut Bergler. Inhibiting eukaryotic ribosome biogenesis. BMC Biology 2019; 17(1) doi: 10.1186/s12915-019-0664-2
|